Cristiana Salgado-Braga

Cristiana Salgado-Braga is a senior global executive known for emerging and Fortune 500/Top 20 Biotech and Biopharma companies, where she has managed €2.5B P&Ls, managed critical pipelines, and is a member of the Johnson & Johnson Innovation Board Fellowship. 

With education and experience that spans both the science and the business of drug and therapy development and marketing, Cristiana is uniquely positioned to help emerging companies gain access, compete effectively, and succeed in new and established markets.  In her most recent experience prior to establishing her own consultancy, Cristiana served as Global VP, Head of Rare Hematologic Diseases, for Sanofi Specialty Care, Cambridge, where she rebuilt the Global Rare Hematology team, serving as business lead for pipeline assets and strategic alliances.  She also led the strategic overhaul of the mature Gaucher Disease Portfolio to deliver four years of double-digit growth.

As the Founder of CS&Bio Consulting, she now serves the biotech industry by advising pre-commercial companies on the critical levers for their launch initiatives, evaluating pipeline strategy, and performing risk assessments.